Want to Calculate Fair Value?
Enter Stock | Calculate Fair Value

Stock: SRPT
Book Value Per Share: $11.63
EPS: $1.57
Diluted EPS TTM: $-2.64
Dividend Per Share: None
Dividend Yield: 0.00 %
Dividend Payout Ratio: 0%
Price To Sales Ratio TTM: 1.655
Price To Book Ratio: 3.234
PEG Ratio: 159.25
EV To EBITDA: 99.06
P/E Ratio: None
Forward P/E Ratio: 24.57
Ex Dividend Date: None
Dividend Date: None
Current Price: $36.18
Previous Close: $37.31
52 Week Low: $34.1
52 Week High: $173.25
Earning Date (within 30 days): N/A
50 Day MA: $52.86
200 Day MA: $103.5
Link to Yahoo (Financial): SRPT
 
* Note: Prices are in Million (M) USD.
Description:
Sarepta Therapeutics Inc (SRPT) ▼
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapies, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. The company is headquartered in Cambridge, Massachusetts.
These criteria used Company’s Cash, EBITDA and Debt balance to determines its fair value:
Cash : $1,103 M
Debt : $1,137 M
EBITDA : $-78 M
Net Debt (Debt - Cash): $34 M

Since Ebitda is less than 0, 0 points assigned.
This criteria used industry in which company operates:
Sector: Healthcare
Industry: Biotechnology

Based on industry, 5 points assigned.
This criteria used Company’s Price To Earning (P/E) Ratio to determines its fair value:
Forward PE Ratio: 23.04

Since Forward PE Ratio is between 20 - 25, 2 points assigned.
This criteria used Company's ability to convert Sales into free cash flow to determine fair value:
Average Free Cash Flow: $-188 M
Average Revenue: $318 M
Free Cash Flow to Revenue : -59 %

Since Free Cash Flow (FCF) to Revenue percentage is negative, 0 point assigned.
This criteria used company's growth potential to calculate its fair value:
Latest Revenue (2024-12-31): $1,902 M
Revenue 4 Years Ago (2020-12-31): $540 M
Last 5 Years Average Revenue Growth: 50%

Since Revenue Growth is greater than 20, 5 points assigned.
This criteria used Company's ability to buy back its own share:
Latest Share Count (2024-12-31): $108 M
Share Count 5 Years Ago (2020-12-31): $78 M

Company is not buying back its own shares, 0 points assigned.
This criteria used Company's dividend payout ratio to determine its fair value:
Earnings Per Share (EPS): $1.57
Dividend Per Share (DPS): $0
Payout Ratio: 0%
Dividend Yield: 0%

Since Dividend Per Share is less than or equal to 0, 0 point assigned.

Since Dividend Yield is less than 1, 0 point assigned.
This criteria used Company's Return On Equity (ROE%) to determine its fair value:
Average ROE: -71%

Since Average ROE is negative, 0 point assigned.
This criteria used Company's current price to its 52 week low price to determines its fair value:
Current Price: $36
52-Week Low: $34
Threshold Price (15% Above 52-Week Low): $39

Since Current price is within 15% threshold, 5 points assigned.
This criteria used Company's Market Cap to determines its fair value:
Market Capitalization: $3,695 M

Since Market Cap is less than 10B, 1 point assigned.
% Exposure to Total Portfolio
Based on the calculated score, we recommend do not exceed 2% exposure of Total Portfolio.
Value-Trade has assigned 18 points to above Sarepta Therapeutics Inc (SRPT) stock.
Twenty Years Avg PE 19, Fair Value PE 20, Industry Based PE is 20 and Growth based PE is 25. Based on these all values average assigned is 21.00.
Value-Trades has assined P/E value 21.00. Since current year earning per share is $1.57.
The fair value of Sarepta Therapeutics Inc (SRPT) stock should be (21.00 x $1.57) = $32.97

Share this valuation:


Advertisement